DRAFTFDA CIRCULAR  
No. ____________ 
SUBJECT  : Updated Guidelines for Payment of Applications with the 
Radiation Regulation Division of the Center for Device 
Regulation, Radiation Health, and Research  (CDRRHR-
RRD),  repealing  FDA Circular No. 2018-004 
I. B
ACKGROUND
 T
he issuance of  the Department of Health (DOH) Administrative Order (AO) No. 2020-
0035 or the “ Rules and Regulations on the Licensing and Registration of Radiation 
Facilities Involved in the Use of Radiation Devices and Issuance of Other related 
Authorizations ” established a more streamlined regulatory process for radiation facilities 
in accordance with  Republic Act  No. 11032, entitled, “ Ease of Doing Business and Efficient 
Government Service Delivery Act of 2018. ” 
The new guideline includes online acceptance, processing, and release of
authorizations through the FDA RRD Portal website. This include sthe generation of Order
of Payment (OP) and posting of payment as an integral part of the online system. As such,
the previous guidelines for payment applications outlined in FDA Circular No. 2018-004, entitled “ Guidelines for Payment of Applications with the Radiation Regulation Division of
the Center for Device Regulation, Radiation Health, and Research (CDRRHR -RRD) ” 
needs  to be revised in view of the new established processes.
II. O
BJECTIVES
 T
his Circular aims to outline , harmonize, and consolidate  the updated guidelines for 
payment of applications with the Radiation Regulation Division of the Center for Device Regulation, Radiation Health, and Research  (CDRRHR- RRD),  repealing FDA Circular 
No. 2018-004.   
III. S
COPE
T
his Circular shall apply to all ra diation facilities in the country under the jurisdiction
of the FDA. 
I
V. GENERAL GUIDELINES
A.T
he current FDA Payment Portal for radiation facilities and devices  based on
FDA Circular No. 2018 -004 at https://rrdpayment.fda.gov.ph/  shall be shutDRAFTdown  taking into account the new payment procedures provided for by FDA 
RRD Portal at https://rrdportal.fda.gov.ph/ . 
 
B. Payment procedures provided for by FDA Circular No. 2020-026 shall apply to 
radiation facilities under the DOH One -Stop Shop (OSS) Licensing System, 
Certificate of Registration (COR) for Magnetic Resonance Imaging (MRI), and 
Clearance for Customs Release (CFCR) . 
 
V. SPECIFIC GUIDELINES  
 
A. Order of P ayment for all radiation facilities  shall be electronically generated 
through the FDA RRD Portal at https://rrdportal.fda.gov.ph/ , except for 
radiation facilities under the DOH One -Stop Shop (OSS) Licensing System, 
Certificate of Registration (COR) for Magnetic Resonance Imaging (MRI), and Clearance for Customs Release (CFCR).  
 
B. Processing of payment  for radiation facilities under the DOH One -Stop Shop 
(OSS) Licensing System, Certificate of Registration (COR) for Magnetic 
Resonance Imaging (MRI), and Clearance for Customs Release (CFCR ) shall 
follow the following procedures:  
 
i. Applications shall be received through the CDRRHR- RRD email at 
cdrrhr.rrd@fda.gov.ph . It shall be subjected  to pre- assessment  and the 
notification of the result shall be sent through the applicant’s email address.  
 
ii. During pre -assessment, applications with complete documentary 
requirements shall be issued an Order of Payment to the applicant's registered email address . 
 
iii. Oncoll payment using the details provided by the O rder of P ayment  shall 
be done at any Land Bank of the Philippines (LBP) branch.  
 
iv. The applicant shall email back  the scanned copy of the proof of 
payment  for the continuation of the process. 
 
C. Payment of fees is not a guarantee that the application will be approved. The 
application shall still be subjected  to the evaluation of FDA and its compliance 
with pertinent laws, rules, and regulations.  
 
   DRAFTVI. SEPARABILITY CLAUSE  
 
 In case any section or provision of this Circular or any part thereof, or the application 
of such section, provision or portion shall be declared invalid, the validity of the remaining provisions of this Circular shall not in any way be affected or impaired thereby.  
VII. REPEALING CLAUSE  
 
 The FDA Circular No. 2018-004 or the “ Guidelines for Payment of Applications with 
the Radiation Regulation Division of the Center for Device Regulation, Radiation Health, and Research (CDRRHR -RRD) ” is hereby repealed. Any other FDA issuances that are  
inconsistent with t he provisions of this Circular are hereby modified or repealed 
accordingly.  VIII.  EFFEC TIVITY  
 
 This Circular shall take effect after fifteen (15) days following its publication in a 
newspaper of general circulation and upon filing three (3) certified copies to the University of the Philippines Law Center.         ROLANDO ENRIQUE D. DOMINGO, MD  
                  Director General  
  
 
Office  FDA-CDRRHR  FDA-PPS FDA-LSSC  
Initialed 
by  
 
MARIA CECILIA C. MATIENZO  
Director IV   
 
IRENE V. FLORENTINO -FARIÑAS, MD, RPh, MNSA  
Officer -in-Charge   
 
ATTY. EMILIO L. POLIG, JR.  
Director IV  
Date     
 DRAFTANNEX A 
 
REFERENCES  
 
Department of Health (DOH) Philippines. (2020). Department of Health (DOH) 
Administrative Order (AO) No. 2020-0035 or the “Rules and Regulations on the 
Licensing and Registration of Radiation Facilities Involved in the Use of Radiation 
Devices and Issuance of Other related Authorizations” . Manila.  
Food and Drug Administration Philippines. (2018). Guidelines for Payment of Applications 
with the Radiation Regulation Division of the Center for Device Regulation, Radiation Health, and Research (CDRRHR- RRD).  Muntinlupa City: FDA. 
Republic Act No. 11032. (2018). Ease of Doing Business and Efficient Government Service 
Delivery Act of 2018.  Manila.  
 
 
 